Kewaunee Scientific Corporation
KEQU · NASDAQ
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 18% | -7.2% | 30% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 28.6% | 25.5% | 16.2% | 14.3% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 9.5% | 8.9% | 3.7% | 0.5% |
| Net Income | $0 | $0 | $0 | -$0 |
| % Margin | 4.7% | 9.2% | 0.6% | -3.6% |
| EPS Diluted | 3.83 | 6.38 | 0.47 | -2.15 |
| % Growth | -40% | 1,257.4% | 121.9% | – |
| Operating Cash Flow | $0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |